The fundamental limitation of non-viral vectors, namely, a poor gene transfer rate, appears to be extremely significant in terms of cancer cell elimination. 135 Furthermore, functional evaluation of non-viral delivery methods like nanoparticles, liposomes, and dendrimers is critical. 136 Clinical results with non-viral vectors for cancer gene therapy seem to be a long way off.
1
—
—